Skip to main content
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. — Investor Relations & Filings

Ticker · MEDP ISIN · US58506Q1094 LEI · 549300H8TYEUVTW14A54 US Professional, scientific and technical activities
Open in API
Filings indexed 859 across all filing types
Latest filing 2016-08-19 Director's Dealing
Country US United States of America
Listing US MEDP

About Medpace Holdings, Inc.

https://investor.medpace.com/

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company serves the biotechnology, pharmaceutical, and medical device industries, with a mission to accelerate the development of safe and effective medical therapeutics. Medpace employs a disciplined operating approach that leverages regulatory and therapeutic expertise. Its services include clinical pharmacology, central laboratory, bioanalytical, ECG core lab, and imaging core labs. The company has expertise across major therapeutic areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective diseases.

Recent filings

Filing Released Lang Actions
FORM 4 SUBMISSION
Director's Dealing
2016-08-19 English
FORM 4 SUBMISSION
Director's Dealing
2016-08-19 English
FORM 4 SUBMISSION
Director's Dealing
2016-08-17 English
FORM 3 SUBMISSION
Director's Dealing
2016-08-16 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K current report filed with the SEC, dated August 16, 2016. It reports amendments to the Certificate of Incorporation and Bylaws of Medpace Holdings, Inc. in connection with the closing of its IPO. It also announces the closing of the IPO and the use of proceeds. The document includes descriptions of corporate governance changes such as establishing a classified board and shareholder voting procedures. There are no financial statements or detailed financial performance data included. The document is primarily an announcement of corporate governance changes and an event (IPO closing), not a full report or financial statement. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other categories.
2016-08-16 English
S-8
Regulatory Filings Classification · 100% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as incentive award plans. It is not a financial report, earnings release, or management discussion. It is a regulatory filing related to securities registration under the Securities Act of 1933. The document includes details about the securities to be registered, indemnification provisions, and legal disclosures typical of registration statements. Therefore, it fits best under Regulatory Filings (RNS) as it does not match any other specific report or announcement category.
2016-08-12 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.